We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Zetia Pay-For-Delay MDL Should Press On, Magistrate Says

Law360 (February 7, 2019, 7:52 PM EST) -- Zetia buyers have sufficiently alleged that Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. kept a generic of the cholesterol medication off the market using a so-called pay-for-delay agreement, a Virginia...
To view the full article, register now.